Our R&D Team

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.

Beatrice Anduze-Faris, M.D.

Vice President, Global Clinical Compliance & Continuous Improvement (GCC&CI), Global Development Operations, Central New Jersey

Michaela Bowden

Director, Translational Biology

Cynthia Brogdon, RN, Ph.D.

Head, Oncology Portfolio Strategy, Oncology Medical

Edgar Charles, M.D.

Clinical Development Lead, Fibrosis R&D, Central New Jersey

Sharon Cload, Ph. D.

Vice President, Molecular Discovery Technologies

Binodh DeSilva, Ph.D.

Vice President, Lead, Discovery and Optimization, Small Molecule Drug Discovery, Central New Jersey

Josh Hansen, Ph.D.

Director, Chemistry, San Diego, CA

Melissa Harris, B.Sc, PharmD

Vice President and Head of Fibrosis Development, Central New Jersey

Evan Janovitz, DVM, Ph.D., DACVP

Director of Pathology, Discovery Toxicology , Central New Jersey

Emma Lees, Ph.D.

Vice President, & Site Head of R&D, Oncology Discovery, Cambridge, MA

Michael May, Ph.D.

Countrywide Medical Director, Germany, Global Medical

Ryan Moslin, Ph.D.

Senior Research Investigator, Early Immunology Discovery, Central New Jersey

Joseph Szustakowski, Ph.D.

Executive Director, Translational Bioinformatics

Saurabh Saha, M.D., Ph.D.

SVP, Global Head of Translational Medicine, Cambridge Site Head

John Throup, BSc, Ph.D.

Development Lead, Immunoscience R&D